CRL - Charles River Laboratories International, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
233,912
241,214
228,424
238,014
Other Short Term Investments
-
1,063
1,024
941
Total Cash
233,912
241,214
228,424
238,014
Net Receivables
752,390
642,881
617,740
514,033
Inventory
255,809
199,146
185,695
160,660
Other Current Assets
107,580
97,311
72,560
56,030
Total Current Assets
1,439,032
1,274,095
1,201,131
1,021,325
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,857,417
1,584,009
1,302,578
1,184,213
Accumulated Depreciation
-1,161,130
-1,102,980
-1,085,993
-977,570
Net property, plant and equipment
1,857,417
1,584,009
1,302,578
1,184,213
Equity and other investments
311,602
201,352
221,804
122,979
Goodwill
2,849,903
2,711,881
1,809,168
1,540,565
Intangible Assets
955,275
1,061,192
787,599
689,413
Other long-term assets
148,279
352,889
352,626
212,615
Total non-current assets
6,163,738
5,750,197
4,289,700
3,671,465
Total Assets
7,602,770
7,024,292
5,490,831
4,692,790
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
2,795
50,214
38,545
Accounts Payable
205,915
198,130
122,475
111,498
Taxes payable
-
26,161
24,884
26,066
Accrued liabilities
219,758
228,797
149,820
139,118
Deferred revenues
264,259
219,703
207,942
171,805
Other Current Liabilities
204,575
137,641
102,477
90,598
Total Current Liabilities
1,091,585
1,033,185
839,751
710,181
Non-current liabilities
Long Term Debt
2,707,531
2,663,564
1,929,571
1,849,666
Deferred taxes liabilities
215,582
239,720
217,031
167,283
Deferred revenues
-
20,578
19,475
20,983
Other long-term liabilities
174,822
242,859
205,215
182,933
Total non-current liabilities
3,487,680
3,399,115
2,507,412
2,316,134
Total Liabilities
4,579,265
4,432,300
3,347,163
3,026,315
Stockholders' Equity
Common Stock
509
505
498
489
Retained Earnings
1,432,901
980,751
625,414
280,329
Accumulated other comprehensive income
-262,057
-164,740
-138,874
-178,019
Total stockholders' equity
2,976,293
2,534,820
2,114,602
1,634,584
Total liabilities and stockholders' equity
7,602,770
7,024,292
5,490,831
4,692,790